Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT07617298
NCT07617298Not yet recruitingNot Applicable

EIT Evaluation of the Impact of Inhaled Nitric Oxide on Ventilation/Perfusion Mismatch in ARDS Patients Receiving Noninvasive Respiratory Support: A Prospective Physiological Study

Ming Zhong1 site in 1 country40 target enrollmentStarted: June 30, 2026Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
40
Locations
1
Study OverviewStudy DesignEligibility CriteriaInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This study aimed to quantitatively evaluate the immediate effect of inhaled nitric oxide on the ventilation / perfusion ratio in ARDS patients receiving nasal high flow oxygen therapy or noninvasive ventilation using electrical impedance tomography.

Detailed Description

The immediate effect of different doses of iNO (5-40 ppm) on the degree of v/q mismatch in the lungs of ARDS patients receiving hfnc or NIV was quantitatively evaluated by EIT. Objective to explore the effects of different doses of iNO on oxygenation, ventilation distribution and perfusion distribution in ARDS patients using hfnc or NIV, as well as the differences and influencing factors of individual response.

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age ≥ 18 years, gender unlimited;
  • •Non invasive ventilation (NIV) with PEEP or CPAP ≥ 5 cmH2O or nasal high flow oxygen therapy (hfnc) with flow rate ≥ 30 l/min met the diagnostic criteria of non intubated ARDS according to the new global definition of ARDS: pao2/fio2 ≤ 300MMHG or spo2/fio2 ≤ 315 (SpO2 ≤ 97%);
  • •Patients with spontaneous breathing and clear consciousness can cooperate with instructions and hold breath for ≥ 8s;
  • •Patients with spontaneous breathing and clear consciousness can cooperate with instructions and hold breath for ≥ 8s;

Exclusion Criteria

  • •There are signs of worsening respiratory failure requiring immediate intubation: respiratory rate > 40 times / min with severe use of auxiliary respiratory muscles or contradictory breathing, or Paco ₂ > 50 mmHg and pH < 7.25;
  • •Hemodynamic instability or the presence of refractory shock; That is, the vasoactive drugs increased by more than 30% within 6 hours, or the norepinephrine dose exceeded 0.5 μ g /kg/min;
  • •There are contraindications to EIT monitoring, such as thoracic implantable defibrillator / pacemaker, large area of severe skin damage on the chest, serious allergy to electrode patches, etc;
  • •There are contraindications to the use of iNO: such as severe left ventricular dysfunction, active bleeding, etc;
  • •Patients with intracranial hypertension, severe arrhythmia or digestive tract obstruction;
  • •Pneumothorax and massive pleural effusion were not treated;
  • •Chronic kidney disease;
  • •Pregnant or lactating women;
  • •Participating in other studies;
  • •The investigator judged that there were any other circumstances not suitable for participation in this study. -

Investigators

Sponsor
Ming Zhong
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Ming Zhong

deputy director

Shanghai Zhongshan Hospital

Study Sites (1)

Loading locations...

Similar Trials

Recruiting
Phase 3
Role of inhaled nitric oxide on right ventricular function and pulmonary vascular mechanics following cardiac surgery
2025-520808-10-00Fundacion Para La Investigacion Biomedica Del Hospital Universitario La Princesa50
Not yet recruiting
Not Applicable
Effect of Inhaled Nitric Oxide Therapy in Adults With Moderate-to-Severe Acute Respiratory Distress Syndrome
NCT07334873Nanfang Hospital, Southern Medical University536
Not yet recruiting
Not Applicable
Estimation of Fractional Exhaled Nitric Oxide and Nasal Nitric Oxide measured among Healthy Adults
CTRI/2025/10/096677Not a sponsored study Institutional resource will be used for the tests200
Completed
Phase 4
Laughing gas for child behavior management in dental clinic
CTRI/2024/07/070023Department of Pediatric and Preventive Dentistry Faculty of dental sciences SGT University30
Recruiting
Not Applicable
Effects of inhaled nitric oxide used for lungs hypertension in critically ill patients.
CTRI/2024/11/076879Dr SUJEET RAI12